Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Multiple Sclerosis

Free Subscription Articles published in Arch Neurol Retrieve available abstracts of 64 articles: HTML format

Single Articles

March 2008
1. KANTARCI OH , Hebrink DD, Schaefer-Klein J, Sun Y, et al
   Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.
   Arch Neurol. 2008;65:349-57.
   PubMed     Related articles    Abstract available
   
   
   
2. HOPPENBROUWERS IA , Liu F, Aulchenko YS, Ebers GC, et al
   Maternal transmission of multiple sclerosis in a dutch population.
   Arch Neurol. 2008;65:345-8.
   PubMed     Related articles    Abstract available
   
   
   February 2008
3. DI PERRI C , Battaglini M, Stromillo ML, Bartolozzi ML, et al
   Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
   Arch Neurol. 2008;65:236-43.
   PubMed     Related articles    Abstract available
   
   
   
4. CHOWDHURY SA , Lin J, Sadiq SA
   Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
   Arch Neurol. 2008;65:232-5.
   PubMed     Related articles    Abstract available
   
   
   
5. EICHEL R , Meiner Z, Abramsky O, Gotkine M, et al
   Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.
   Arch Neurol. 2008;65:267-71.
   PubMed     Related articles    Abstract available
   
   
   January 2008
6. BYUN E , Caillier SJ, Montalban X, Villoslada P, et al
   Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis.
   Arch Neurol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. HAMMOND ER , Kerr DA
   Ethanol responsive tremor in a patient with multiple sclerosis.
   Arch Neurol. 2008;65:142-3.
   PubMed     Related articles   
   
   
   
8. FROHMAN EM , Costello F, Stuve O, Calabresi P, et al
   Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis.
   Arch Neurol. 2008;65:26-35.
   PubMed     Related articles    Abstract available
   
   
   
9. BLANC F , Zephir H, Lebrun C, Labauge P, et al
   Cognitive functions in neuromyelitis optica.
   Arch Neurol. 2008;65:84-8.
   PubMed     Related articles    Abstract available
   
   
   
10. PITTOCK SJ , Lennon VA, de Seze J, Vermersch P, et al
    Neuromyelitis optica and non organ-specific autoimmunity.
    Arch Neurol. 2008;65:78-83.
    PubMed     Related articles    Abstract available
    
    
    December 2007
11. MINAGAR A , Alexander JS, Schwendimann RN, Kelley RE, et al
    Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis: An Open-Label Trial.
    Arch Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
12. FRANCIOTTA D , Jarius S, Aloisi F
    More on multiple sclerosis and neuromyelitis optica.
    Arch Neurol. 2007;64:1802.
    PubMed     Related articles   
    
    
    October 2007
13. BENEDETTI L , Franciotta D, Vigo T, Grandis M, et al
    Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy.
    Arch Neurol. 2007;64:1531-3.
    PubMed     Related articles    Abstract available
    
    
    
14. CALABRESE M , De Stefano N, Atzori M, Bernardi V, et al
    Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
    Arch Neurol. 2007;64:1416-22.
    PubMed     Related articles    Abstract available
    
    
    
15. STUVE O , Eagar TN, Frohman EM, Cravens PD, et al
    DNA plasmid vaccination for multiple sclerosis.
    Arch Neurol. 2007;64:1385-6.
    PubMed     Related articles   
    
    
    
16. DE SEZE J , Debouverie M, Zephir H, Lebrun C, et al
    Acute fulminant demyelinating disease: a descriptive study of 60 patients.
    Arch Neurol. 2007;64:1426-32.
    PubMed     Related articles    Abstract available
    
    
    September 2007
17. FRAZER ML , Benson JT, Hashemi CA, Lee H, et al
    Spinchter Symptoms as Predictors of Long-term Disability in Multiple Sclerosis.
    Arch Neurol. 2007;64:1359.
    PubMed     Related articles   
    
    
    
18. AGOSTA F , Pagani E, Caputo D, Filippi M, et al
    Associations between cervical cord gray matter damage and disability in patients with multiple sclerosis.
    Arch Neurol. 2007;64:1302-5.
    PubMed     Related articles    Abstract available
    
    
    
19. KRUMBHOLZ M , Pellkofer H, Gold R, Hoffmann LA, et al
    Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.
    Arch Neurol. 2007;64:1331-3.
    PubMed     Related articles    Abstract available
    
    
    
20. BARKHOF F , Polman CH, Radue EW, Kappos L, et al
    Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
    Arch Neurol. 2007;64:1292-8.
    PubMed     Related articles    Abstract available
    
    
    August 2007
21. BAR-OR A , Vollmer T, Antel J, Arnold DL, et al
    Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial.
    Arch Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. PULIZZI A , Rovaris M, Judica E, Sormani MP, et al
    Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Arch Neurol. 2007;64:1163-8.
    PubMed     Related articles    Abstract available
    
    
    
23. AMATO MP , Portaccio E, Goretti B, Zipoli V, et al
    Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Arch Neurol. 2007;64:1157-61.
    PubMed     Related articles    Abstract available
    
    
    
24. BRALEY T , Mikol DD
    Neuromyelitis optica in a mother and daughter.
    Arch Neurol. 2007;64:1189-92.
    PubMed     Related articles    Abstract available
    
    
    July 2007
25. STUVE O , Cravens PD, Singh MP, Frohman EM, et al
    High incidence of post-lumbar puncture headaches in patients with multiple sclerosis treated with natalizumab: role of intrathecal leukocytes.
    Arch Neurol. 2007;64:1055-6.
    PubMed     Related articles   
    
    
    June 2007
26. FROHMAN EM , Kerr D
    Is neuromyelitis optica distinct from multiple sclerosis?: something for "lumpers" and "splitters".
    Arch Neurol. 2007;64:903-5.
    PubMed     Related articles   
    
    
    
27. GALETTA SL , Bennett J
    Neuromyelitis optica is a variant of multiple sclerosis.
    Arch Neurol. 2007;64:901-3.
    PubMed     Related articles   
    
    
    
28. WEINSHENKER BG
    Neuromyelitis optica is distinct from multiple sclerosis.
    Arch Neurol. 2007;64:899-901.
    PubMed     Related articles   
    
    
    
29. ROACH ES
    Is neuromyelitis optica a distinct entity?
    Arch Neurol. 2007;64:906.
    PubMed     Related articles   
    
    
    May 2007
30. SICOTTE NL , Giesser BS, Tandon V, Klutch R, et al
    Testosterone treatment in multiple sclerosis: a pilot study.
    Arch Neurol. 2007;64:683-8.
    PubMed     Related articles    Abstract available
    
    
    March 2007
31. MANFREDONIA F , Ciccarelli O, Khaleeli Z, Tozer DJ, et al
    Normal-appearing brain t1 relaxation time predicts disability in early primary progressive multiple sclerosis.
    Arch Neurol. 2007;64:411-5.
    PubMed     Related articles    Abstract available
    
    
    
32. FROHMAN EM , Stuve O, Miller DH
    W. Ian McDonald, MB, ChB, PhD (1933-2006): the multiple sclerosis physician-scientist of the 20th century.
    Arch Neurol. 2007;64:452-4.
    PubMed     Related articles   
    
    
    February 2007
33. INGLESE M , Park SJ, Johnson G, Babb JS, et al
    Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T.
    Arch Neurol. 2007;64:196-202.
    PubMed     Related articles    Abstract available
    
    
    
34. JASPERSE B , Minneboo A, de Groot V, Kalkers NF, et al
    Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis.
    Arch Neurol. 2007;64:190-4.
    PubMed     Related articles    Abstract available
    
    
    
35. PHILLIPS JT
    What causes multiple sclerosis to worsen?
    Arch Neurol. 2007;64:167-8.
    PubMed     Related articles   
    
    
    
36. GUIMARAES J , Sa MJ
    Devic disease with abnormal brain magnetic resonance image findings: the first Portuguese case.
    Arch Neurol. 2007;64:290-1.
    PubMed     Related articles   
    
    
    January 2007
37. BO L , Geurts JJ, van der Valk P, Polman C, et al
    Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
    Arch Neurol. 2007;64:76-80.
    PubMed     Related articles    Abstract available
    
    
    
38. NIELSEN TR , Rostgaard K, Nielsen NM, Koch-Henriksen N, et al
    Multiple sclerosis after infectious mononucleosis.
    Arch Neurol. 2007;64:72-5.
    PubMed     Related articles    Abstract available
    
    
    December 2006
39. LANGER-GOULD A , Popat RA, Huang SM, Cobb K, et al
    Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis: A Systematic Review.
    Arch Neurol. 2006;63:1686-91.
    PubMed     Related articles    Abstract available
    
    
    November 2006
40. CHADHA K , Weinstock-Guttman B, Zivadinov R, Bhasi K, et al
    Interferon inhibitory activity in patients with multiple sclerosis.
    Arch Neurol. 2006;63:1579-84.
    PubMed     Related articles    Abstract available
    
    
    
41. KOPADZE T , Dehmel T, Hartung HP, Stuve O, et al
    Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis.
    Arch Neurol. 2006;63:1572-8.
    PubMed     Related articles    Abstract available
    
    
    October 2006
42. STUVE O , Marra CM, Bar-Or A, Niino M, et al
    Altered CD4+/CD8+ T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Arch Neurol. 2006;63:1383-7.
    PubMed     Related articles    Abstract available
    
    
    
43. SCOTT TF , Kassab SL, Pittock SJ
    Neuromyelitis optica IgG status in acute partial transverse myelitis.
    Arch Neurol. 2006;63:1398-400.
    PubMed     Related articles    Abstract available
    
    
    September 2006
44. BENEDICT RH , Bruce JM, Dwyer MG, Abdelrahman N, et al
    Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
    Arch Neurol. 2006;63:1301-6.
    PubMed     Related articles    Abstract available
    
    
    
45. SHAPIRO AM , Jack CS, Lapierre Y, Arbour N, et al
    Potential for interferon Beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous system.
    Arch Neurol. 2006;63:1296-9.
    PubMed     Related articles    Abstract available
    
    
    August 2006
46. GLADSTONE DE , Zamkoff KW, Krupp L, Peyster R, et al
    High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis.
    Arch Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
47. SEPULCRE J , Sastre-Garriga J, Cercignani M, Ingle GT, et al
    Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study.
    Arch Neurol. 2006;63:1175-80.
    PubMed     Related articles    Abstract available
    
    
    July 2006
48. WINGERCHUK DM , Rodriguez M
    Premenstrual multiple sclerosis pseudoexacerbations: role of body temperature and prevention with aspirin.
    Arch Neurol. 2006;63:1005-8.
    PubMed     Related articles    Abstract available
    
    
    
49. NIELSEN NM , Westergaard T, Frisch M, Rostgaard K, et al
    Type 1 diabetes and multiple sclerosis: a danish population-based cohort study.
    Arch Neurol. 2006;63:1001-4.
    PubMed     Related articles    Abstract available
    
    
    
50. PITTOCK SJ , Weinshenker BG, Lucchinetti CF, Wingerchuk DM, et al
    Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
    Arch Neurol. 2006;63:964-8.
    PubMed     Related articles    Abstract available
    
    
    
51. WEINSTOCK-GUTTMAN B , Ramanathan M, Lincoff N, Napoli SQ, et al
    Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).
    Arch Neurol. 2006;63:957-63.
    PubMed     Related articles    Abstract available
    
    
    June 2006
52. FRASER C , Klistorner A, Graham S, Garrick R, et al
    Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
    Arch Neurol. 2006;63:847-50.
    PubMed     Related articles    Abstract available
    
    
    
53. LOVETT-RACKE AE , Racke MK
    Epstein-Barr virus and multiple sclerosis.
    Arch Neurol. 2006;63:810-1.
    PubMed     Related articles   
    
    
    
54. KISTER I , Gulati S, Boz C, Bergamaschi R, et al
    Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy.
    Arch Neurol. 2006;63:851-6.
    PubMed     Related articles    Abstract available
    
    
    May 2006
55. CRAWFORD CL , Hardwicke PM
    Characterizing the mechanisms and progression in multiple sclerosis: evidence and new hypotheses for future directions.
    Arch Neurol. 2006;63:786-7.
    PubMed     Related articles   
    
    
    
56. OREJA-GUEVARA C , Charil A, Caputo D, Cavarretta R, et al
    Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Arch Neurol. 2006;63:736-40.
    PubMed     Related articles    Abstract available
    
    
    April 2006
57. DELORENZE GN , Munger KL, Lennette ET, Orentreich N, et al
    Epstein-Barr Virus and Multiple Sclerosis: Evidence of Association From a Prospective Study With Long-term Follow-up.
    Arch Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
58. ROACH ES
    Early multiple sclerosis: to treat or not to treat?
    Arch Neurol. 2006;63:619.
    PubMed     Related articles   
    
    
    
59. FROHMAN EM , Havrdova E, Lublin F, Barkhof F, et al
    Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
    Arch Neurol. 2006;63:614-9.
    PubMed     Related articles   
    
    
    
60. PITTOCK SJ , Weinshenker BG, Noseworthy JH, Lucchinetti CF, et al
    Not every patient with multiple sclerosis should be treated at time of diagnosis.
    Arch Neurol. 2006;63:611-4.
    PubMed     Related articles   
    
    
    
61. MATHIESEN HK , Jonsson A, Tscherning T, Hanson LG, et al
    Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
    Arch Neurol. 2006;63:533-6.
    PubMed     Related articles    Abstract available
    
    
    
62. CANTOR FK
    Interferon beta-1a treatment and African Americans.
    Arch Neurol. 2006;63:627-8.
    PubMed     Related articles   
    
    
    
63. CHALUMEAU-LEMOINE L , Chretien F, Gaelle Si Larbi A, Brugieres P, et al
    Devic disease with brainstem lesions.
    Arch Neurol. 2006;63:591-3.
    PubMed     Related articles    Abstract available
    
    
    March 2006
64. PITTOCK SJ , Lennon VA, Krecke K, Wingerchuk DM, et al
    Brain abnormalities in neuromyelitis optica.
    Arch Neurol. 2006;63:390-6.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Bernd Sebastian Kamps website.    Design: